5-177600185-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_007255.3(B4GALT7):​c.-26C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00351 in 1,342,070 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0021 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0037 ( 10 hom. )

Consequence

B4GALT7
NM_007255.3 5_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.417

Publications

0 publications found
Variant links:
Genes affected
B4GALT7 (HGNC:930): (beta-1,4-galactosyltransferase 7) This gene is a member of the beta-1,4-galactosyltransferase (beta4GalT) family. Family members encode type II membrane-bound glycoproteins that appear to have exclusive specificity for the donor substrate UDP-galactose. Each beta4GalT member has a distinct function in the biosynthesis of different glycoconjugates and saccharide structures. As type II membrane proteins, they have an N-terminal hydrophobic signal sequence that directs the protein to the Golgi apparatus which then remains uncleaved to function as a transmembrane anchor. The enzyme encoded by this gene attaches the first galactose in the common carbohydrate-protein linkage (GlcA-beta1,3-Gal-beta1,3-Gal-beta1,4-Xyl-beta1-O-Ser) found in proteoglycans. This enzyme differs from other beta4GalTs because it lacks the conserved Cys residues found in beta4GalT1-beta4GalT6 and it is located in cis-Golgi instead of trans-Golgi. Mutations in this gene have been associated with the progeroid form of Ehlers-Danlos syndrome. [provided by RefSeq, Oct 2009]
B4GALT7 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome, spondylodysplastic type, 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P, Ambry Genetics
  • Ehlers-Danlos syndrome, spondylodysplastic type
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 5-177600185-C-T is Benign according to our data. Variant chr5-177600185-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 384811.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00212 (321/151728) while in subpopulation NFE AF = 0.00351 (238/67842). AF 95% confidence interval is 0.00314. There are 1 homozygotes in GnomAd4. There are 165 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 10 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
B4GALT7NM_007255.3 linkc.-26C>T 5_prime_UTR_variant Exon 1 of 6 ENST00000029410.10 NP_009186.1 Q9UBV7
B4GALT7XM_047416681.1 linkc.-1136C>T 5_prime_UTR_variant Exon 1 of 7 XP_047272637.1
B4GALT7XM_047416682.1 linkc.-421C>T 5_prime_UTR_variant Exon 1 of 7 XP_047272638.1
B4GALT7XM_047416680.1 linkc.-2301C>T upstream_gene_variant XP_047272636.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
B4GALT7ENST00000029410.10 linkc.-26C>T 5_prime_UTR_variant Exon 1 of 6 1 NM_007255.3 ENSP00000029410.5 Q9UBV7

Frequencies

GnomAD3 genomes
AF:
0.00212
AC:
321
AN:
151620
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000774
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00210
Gnomad ASJ
AF:
0.000578
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.000479
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00351
Gnomad OTH
AF:
0.00240
GnomAD2 exomes
AF:
0.00161
AC:
71
AN:
43976
AF XY:
0.00195
show subpopulations
Gnomad AFR exome
AF:
0.00171
Gnomad AMR exome
AF:
0.000610
Gnomad ASJ exome
AF:
0.000520
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00106
Gnomad NFE exome
AF:
0.00289
Gnomad OTH exome
AF:
0.00229
GnomAD4 exome
AF:
0.00369
AC:
4387
AN:
1190342
Hom.:
10
Cov.:
30
AF XY:
0.00364
AC XY:
2114
AN XY:
580118
show subpopulations
African (AFR)
AF:
0.000533
AC:
13
AN:
24410
American (AMR)
AF:
0.00103
AC:
18
AN:
17486
Ashkenazi Jewish (ASJ)
AF:
0.000698
AC:
13
AN:
18632
East Asian (EAS)
AF:
0.00
AC:
0
AN:
26802
South Asian (SAS)
AF:
0.000910
AC:
47
AN:
51672
European-Finnish (FIN)
AF:
0.000510
AC:
14
AN:
27444
Middle Eastern (MID)
AF:
0.000302
AC:
1
AN:
3316
European-Non Finnish (NFE)
AF:
0.00425
AC:
4139
AN:
973000
Other (OTH)
AF:
0.00298
AC:
142
AN:
47580
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
195
391
586
782
977
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
170
340
510
680
850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00212
AC:
321
AN:
151728
Hom.:
1
Cov.:
32
AF XY:
0.00222
AC XY:
165
AN XY:
74158
show subpopulations
African (AFR)
AF:
0.000772
AC:
32
AN:
41476
American (AMR)
AF:
0.00210
AC:
32
AN:
15244
Ashkenazi Jewish (ASJ)
AF:
0.000578
AC:
2
AN:
3460
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5138
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4826
European-Finnish (FIN)
AF:
0.000479
AC:
5
AN:
10432
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00351
AC:
238
AN:
67842
Other (OTH)
AF:
0.00237
AC:
5
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
19
38
56
75
94
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000849
Hom.:
0
Bravo
AF:
0.00209
Asia WGS
AF:
0.000290
AC:
1
AN:
3466

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Jan 30, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.71
CADD
Benign
15
DANN
Benign
0.95
PhyloP100
0.42
PromoterAI
0.058
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=300/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs530248269; hg19: chr5-177027186; API